| [Efficacy and safety of vitamin D in the treatment of idiopathic oligoasthenozoospermia] 2014 · control group · Men with idiopathic oligoasthenozoospermia | 300 mg | 300 mg | 90 days | 43 |
| [A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia] 2005 · control group · men with oligoasthenozoospermia | 300 mg | 300 mg | 90 days | — |
| Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis 2000 · combination of vitamins E and C · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L | 182 mg | 500 mg | 3 years | — |
| Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial 2014 · vitamin C and E group · young men and women undergoing endurance training; age range and health condition not stated | 235 mg | 1 g | 11 weeks | — |
| Vitamin C and E supplementation blunts increases in total lean body mass in elderly men after strength training 2016 · antioxidant group · Men aged 60–81 years participating in strength training | 235 mg | 1 g | 12 weeks | — |
| Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis 2015 · Vitamin C and E supplementation · Pregnant low-risk nulliparous women with singleton gestations; the reported subgroup analysis included women who smoked during pregnancy | 400 IU | 1 g | — | 4,993 |
| Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial 2010 · vitamin C and E supplementation · Low-risk nulliparous women with singleton pregnancies, enrolled at 9 weeks 0 days to 16 weeks 6 days of gestation | 400 IU | 1 g | — | 4,992 |
| Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori 2012 · Group A · Patients with Helicobacter pylori infection | 400 IU | 1 g | 30 days | 160 |
| Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori 2012 · Group A · Patients with Helicobacter pylori infection | 400 IU | 1 g | 30 days | 160 |
| Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial 1999 · vitamin group · Women at increased risk of pre-eclampsia, enrolled at 16–22 weeks’ gestation | 400 IU | 1 g | — | 141 |
| A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement 2013 · supplemented group · Patients scheduled for on-pump cardiac surgery; age and sex not specified | 400 IU | 1 g | — | 103 |
| Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? 2009 · group B · Patients with Helicobacter pylori infection; age range and sex not reported | 400 IU | 1 g | 30 days | 80 |
| Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with low antioxidant capacity 2011 · Group A · Patients with H. pylori-positive nonulcer dyspepsia, chronic stress, and low total antioxidant capacity | 400 IU | 1 g | 30 days | 80 |
| MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience 1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension | 600 mg | 250 mg | 5 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 400 IU | 500 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants | 400 IU | 500 mg | 339 weeks | — |
| Vitamins C and E in the latency period in women with preterm premature rupture of membranes 2005 · vitamin C and vitamin E · Women with singleton pregnancies at 26 to 34 weeks' gestation and PPROM | 400 IU | 500 mg | — | — |
| Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial 2005 · antioxidant vitamins · Adults with acute myocardial infarction; mean age 62 years | 600 mg | 1.2 g | 30 days | — |
| Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial 2011 · daily combination of atorvastatin, vitamin C, and vitamin E · Men and women aged 50–70 years; healthy individuals, including a subgroup with NAFLD at baseline | 1,000 IU | 1 g | 1314 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 400 IU | 500 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 400 IU | 500 mg | 9 years | — |
| Investigating the preventive effect of vitamins C and E on preeclampsia in nulliparous pregnant women 2020 · intervention group · Nulliparous pregnant women aged 18–38 years without risk factors for preeclampsia | 400 IU | 1 g | — | — |
| Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16 1993 · Group 1 (vitamins) · Individuals after endoscopic polypectomy; age and sex not reported; adenomas were the condition of interest. | 70 mg | 1 g | 548 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline | 15 mg | 120 mg | 2 years | — |
| Effects of vitamins C and E supplementation combined with 12-week resistance training in older women with sarcopenia: A randomized, double-blind, placebo-controlled trial 2025 · Antioxidant supplementation group (AS) · Women aged 60–75 with sarcopenia; all participants had inadequate baseline vitamin C status, and most had inadequate vitamin E status. | 335 mg | 1 g | 12 weeks | 30 |
| Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements 1999 · vitamin group · Dutch bicyclists; adults, with no stated medical condition, studied during exercise in ozone exposure | 100 mg | 500 mg | 15 weeks | 20 |
| A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps 2001 · combination of vitamins E and C · haemodialysis patients with end-stage renal disease; age and sex not specified | 400 mg | 250 mg | 8 weeks | 15 |
| Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial 2012 · vitamin C (200 mg) and vitamin E (400 mg) · Hemodialysis patients with restless legs syndrome | 400 mg | 200 mg | 8 weeks | 15 |
| Attenuation of angiotensin converting enzyme inhibitor induced cough by iron supplementation: role of nitric oxide 2011 · anti-oxidant group · Patients with cough while receiving ACE-inhibitor therapy; age and sex not reported | 200 mg | 150 mg | 4 weeks | 8 |
| Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma 2005 · Antioxidants in addition to standard antiasthmatic therapy · Adults aged 25–50 with persistent mild to moderate bronchial asthma | 400 mg | 250 mg | 16 weeks | — |
| The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial 2014 · antioxidant supplementation · Adults aged 60–75 years with mild cognitive impairment | 300 mg | 400 mg | 1 year | — |
| High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men 2017 · antioxidant group (AO) · Healthy elderly men; age range not reported (mean age 70 ± 7 years) | 235 mg | 1 g | 12 weeks | 16 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 7.5 mg | 40.2 mg | 1 year | 316 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 30 mg | 180 mg | 5 years | 164 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 30 mg | 120 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 400 IU | 500 mg | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 8 mg | 50 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 10 mg | 100 mg | — | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 400 IU | 500 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 30 mg | 120 mg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 30 mg | 120 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 30 mg | 120 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 30 mg | 120 mg | 2738 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 30 mg | 120 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 400 IU | 500 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 400 IU | 500 mg | 9 years | — |
| Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women 2014 · multivitamins without vitamin A · HIV-infected pregnant women in Tanzania | 30 mg | 500 mg | 1249 days | — |
| Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women 2014 · multivitamins with vitamin A · HIV-infected pregnant women in Tanzania | 30 mg | 500 mg | 1249 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 15 mg | 120 mg | 2 years | — |
| Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants 1998 · active medication · Adults with colorectal polyps; age range and sex not stated | 75 mg | 150 mg | 3 years | — |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 400 mg | 500 mg | 17 weeks | 26 |
| Antioxidant supplementation reduces endometriosis-related pelvic pain in humans 2013 · Group A · Women aged 19–41 with pelvic pain and a history of endometriosis and/or infertility | 1,200 IU | 1 g | 8 weeks | 46 |
| Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction 1996 · supplemented group · Patients with acute myocardial infarction | 600 mg | 600 mg | 2 weeks | 33 |
| Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery? 2013 · vitamins C + E group (group 2) · Adults with angiographically confirmed significant coronary artery disease awaiting coronary artery bypass surgery | 600 IU | 2 g | 1 day | 31 |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · moderate vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 75 IU | 300 mg | 1 day | 30 |
| Acute autonomic effects of vitamins and fats in male smokers 2009 · high doses of vitamins · Male smokers, mean age 34.2 years (SD 6.9) | 800 IU | 2 g | 1 day | 30 |
| Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer 2016 · trial group · Patients with head and neck cancer receiving radiotherapy; age and sex not reported | 200 IU | 1 g | — | 25 |
| Protective effect of anti-oxidants on endothelial function in young Korean-Asians compared to Caucasians 2012 · antioxidant vitamins · Healthy Korean and Caucasian adults aged 20–35 years | 800 IU | 1 g | 2 weeks | 20 |
| Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal 1997 · high-fat meal with vitamins · Healthy, normocholesterolemic men and women aged 24 to 54 years | 800 IU | 1 g | 1 day | 20 |
| Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins 2004 · methionine load with antioxidant vitamins · Healthy volunteers aged 26–40 years; nine men and seven women, with no stated condition | 800 IU | 1 g | 1 day | 16 |
| Effect of strength training combined with antioxidant supplementation on muscular performance 2018 · vitamins · Women, mean age 23.8 years, participating in strength training; no diagnosed condition stated | 400 IU | 1 g | 10 weeks | 15 |
| Improved lung function following dietary antioxidant supplementation in exercise-induced asthmatics 2016 · Vitamins (V) · Adults with exercise-induced asthma (mean age 22.0 years) and healthy controls (mean age 28.2 years) | 300 IU | 500 mg | 3 weeks | 13 |
| Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements 1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated | 75 mg | 650 mg | 90 days | 12 |
| Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal 1997 · low-fat meal with vitamins · A subgroup of healthy, normocholesterolemic men and women aged 24 to 54 years | 800 IU | 1 g | 1 day | 10 |
| Effect of vitamin supplementation on lung injury and running performance in a hot, humid, and ozone-polluted environment 2011 · Vitamin trial · Runners; age, sex, and health condition not specified | 100 IU | 500 mg | 2 weeks | 9 |
| The effects of acute oral antioxidants on diving-induced alterations in human cardiovascular function 2007 · acute antioxidants · Experienced divers; age and sex not reported | 400 IU | 2 g | 1 day | 6 |
| Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis 2011 · Subgroup A · Patients with early diffuse systemic sclerosis, positive anti-topoisomerase-I antibody, high skin thickening progression rate and decreased lung diffusing capacity; age and sex not reported | 400 IU | 1 g | 26 weeks | 6 |
| The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract 2002 · vitamin group · Adult American and English outpatients with early age-related cataract | 600 mg | 750 mg | 3 years | — |
| UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose 2002 · Group 3 · Healthy volunteers | 1,200 IU | 2 g | 7 days | — |
| Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants 2002 · vitamin supplement group · Children with asthma living in Mexico City; age and asthma severity not specified | 50 mg | 250 mg | — | — |
| Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study 2003 · supplemented group · Men and postmenopausal women aged 45–69 years, smoking or nonsmoking, with serum cholesterol ≥5.0 mmol/L | 272 IU | 500 mg | 6 years | — |
| Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus 2003 · oral antioxidant therapy · People with Type 1 or Type 2 diabetes and matched healthy control subjects; ages and sex not reported | 800 IU | 1 g | 26 weeks | — |
| Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial 2003 · antioxidant vitamin therapy · children with familial hypercholesterolemia or the phenotype of familial combined hyperlipidemia | 400 IU | 500 mg | 6 weeks | — |
| Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis 2003 · vitamins E and C · Patients with nonalcoholic steatohepatitis (NASH); age and sex not specified | 1,000 IU | 1 g | 26 weeks | — |
| Effects of dietary supplementation with vitamins C and E on muscle function during and after eccentric contractions in humans 2004 · treatment group · male volunteers; no age range or diagnosed condition reported | 1,200 IU | 500 mg | 37 days | — |
| Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial 2015 · Antioxidant vitamins · Children conceived by assisted reproductive technology (ART) | 400 IU | 1 g | 4 weeks | — |
| Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial 2015 · Antioxidant vitamins · Control children (children not conceived by assisted reproductive technology) | 400 IU | 1 g | 4 weeks | — |
| Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction 2016 · HA group (high ascorbate, >1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty | 400 IU | 1 g | 12 weeks | — |
| Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction 2016 · LA group (low ascorbate, <1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty | 400 IU | 1 g | 12 weeks | — |
| Mechanical Ventilation Antioxidant Trial 2015 · vitamin C plus vitamin E · critically ill adults requiring mechanical ventilation | 3,000 IU | 3 g | — | — |
| Mechanical Ventilation Antioxidant Trial 2015 · vitamin C plus vitamin E plus N-acetylcysteine · critically ill adults requiring mechanical ventilation | 3,000 IU | 3 g | — | — |
| Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E) 1998 · vitamins C and E · Human subjects; age, sex, and health status not specified; assessed for sunburn response | 1,000 IU | 2 g | 8 days | — |
| Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone 1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated | 75 mg | 650 mg | 26 weeks | — |
| Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation 1998 · Group (3) · Healthy volunteers | 2 g | 3 g | 50 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group V · People with type 2 diabetes; age and sex not reported | 150 mg | 200 mg | 90 days | 18 |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 7.5 mg | 40.2 mg | 1 year | 316 |
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 250 mg | 250 mg | 14 weeks | 55 |
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 30 mg | 180 mg | 14 weeks | 55 |
| A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study 2019 · verum group · Women aged 35–73 with healthy skin | 2.3 mg | 80 mg | 12 weeks | 36 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Colostrum + Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 200 mg | — | 10 weeks | 35 |
| [Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis] 2004 · Karinat · Patients with chronic multifocal atrophic gastritis | 10 mg | 60 mg | 26 weeks | 34 |
| [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease] 2004 · Karinat · Patients with benign breast disease, including mastopathy | 10 mg | 60 mg | 26 weeks | 33 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 200 mg | — | 10 weeks | 31 |
| Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training 2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training | 305 mg | 500 mg | 2 days | 31 |
| A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement 2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease | 2.3 mg | 80 mg | 12 weeks | 30 |
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 1999 · Methionine load with antioxidant vitamins · Healthy adults aged 25 to 45 years; 10 men and 10 women | 800 IU | 1 g | 1 day | 20 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 30 mg | 180 mg | 1 year | 15 |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 30 mg | 120 mg | 2922 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group MV · People with type 2 diabetes; age and sex not reported | 150 mg | 200 mg | 90 days | 17 |
| Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly 2010 · Tx1 · Older adults aged approximately 68 years, men and women, healthy or with controlled chronic disease | 400 IU | 500 mg | 1 year | 30 |
| Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly 2010 · Tx2 · Older adults aged approximately 69 years, men and women, healthy or with controlled chronic disease | 400 IU | 1 g | 1 year | 30 |
| Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males 2004 · vitamin intervention · 31 young healthy male adults; 14 received the vitamin intervention | 800 mg | 1 g | 12 weeks | 14 |
| Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study 2009 · antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy | 600 mg | 1 g | 26 weeks | 8 |
| Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study 2009 · exercise and antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy | 600 mg | 1 g | 26 weeks | 8 |
| Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension 2008 · vitamins C+E · Men aged 35–60 with grade 1 essential hypertension, without obesity, dyslipidaemia or diabetes | 400 IU | 1 g | 8 weeks | — |
| Effect of Omega-3 and Vitamins E + C Supplements on the Concentration of Serum B-Vitamins and Plasma Redox Aminothiol Antioxidant Status in Elderly Men after Strength Training for Three Months 2016 · group III · Healthy men, mean age 60 ± 6 years, undertaking strength training | 235 mg | 1 g | 90 days | 16 |
| Vitamin C pharmacokinetics of plain and slow release formulations in smokers 2004 · Plain-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day | 182 mg | 500 mg | 4 weeks | — |
| Vitamin C pharmacokinetics of plain and slow release formulations in smokers 2004 · Slow-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day | 182 mg | 500 mg | 4 weeks | — |
| Plasma vitamin C and tocotrienols changes in response to dietary supplementation among young male adults 2010 · Combination · young male police recruits | 200 mg | 500 mg | 8 weeks | — |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 600 mg | 500 mg | 8 weeks | — |
| Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients 1999 · vitamin group · Patients with acute anterior uveitis; age and sex not specified | 200 mg | 1 g | 8 weeks | — |
| Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men 2000 · vitamin C and vitamin E combination · men described as nondepleted; age and condition not stated | 182 mg | 500 mg | 3 years | — |
| Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men 2001 · both vitamins group (CellaVie) · Clinically healthy men with mild hypercholesterolemia and normal vitamin C and E levels | 200 mg | 500 mg | 1 year | — |
| Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers 2004 · Slow-release vitamin C with plain-release vitamin E · Male smokers | 182 mg | 500 mg | 4 weeks | — |
| Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers 2004 · Plain-release vitamin C with plain-release vitamin E · Male smokers | 182 mg | 500 mg | 4 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 4 · Adults aged 60–75 years; elderly participants | 200 mg | 300 mg | 16 weeks | — |
| Partial resistance of low density lipoprotein to oxidation in vivo after increased intake of berries 2000 · supplement group · Healthy 60-year-old men | 100 mg | 500 mg | 8 weeks | 20 |
| Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation 2012 · antioxidant supplemented sedentary group (AS) · Healthy septuagenarians, men and women, mean age 73.4 years; no stated disease or nutrient deficiency. | 100 mg | 500 mg | 8 weeks | 8 |
| Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation 2012 · antioxidant supplemented and aerobically trained group (AT) · Healthy septuagenarians, men and women, mean age 75.8 years; no stated disease or nutrient deficiency. | 100 mg | 500 mg | 8 weeks | 8 |
| Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients 2005 · Control group · Patients with chronic hepatitis C receiving interferon alpha-2b and ribavirin; age and sex not reported | 300 mg | 600 mg | 24 weeks | 5 |
| Combination treatment with high-dose vitamin C and alpha-tocopherol does not enhance respiratory-tract lining fluid vitamin C levels in asthmatics 2009 · 500 mg tocopherol and 2 g vitamin C · Adults aged 18–50 with allergic moderate-to-severe persistent asthma | 500 mg | 2 g | 12 weeks | — |
| [Synergistic antioxidative effect of vitamins E and C on low density lipoproteins from smokers and non-smokers subjects] 2004 · vitamins E and C combination · 20 healthy adult smokers and 10 healthy adult non-smokers | 400 mg | 1 g | 30 days | 30 |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group V · Adults with type 2 diabetes; age and sex not reported | 150 mg | 200 mg | 90 days | 18 |
| Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin 2006 · vitamin group · Patients with chronic hepatitis C receiving interferon-alpha-2b and ribavirin combination therapy; age and sex not reported | 500 mg | 750 mg | 8 weeks | 14 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · control group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 300 mg | 600 mg | 48 weeks | 12 |
| Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners 2004 · antioxidants (AO) · Ultramarathon runners participating in a 50 km race; age and sex distribution not reported | 300 mg | 1 g | 6 weeks | 11 |
| Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults 1996 · vitamins C and E group · healthy adults; age range and sex not reported | 400 mg | 1 g | 4 weeks | 10 |
| Increased serum and low-density-lipoprotein antioxidant potential after antioxidant supplementation in endurance athletes 1997 · antioxidant trial · Eight endurance athletes | 294 mg | 1 g | 4 weeks | 8 |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · nonsmokers receiving vitamin cocktail · Male nonsmokers selected for low fruit and vegetable intake | 31 mg | 272 mg | 90 days | 38 |
| Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes 2000 · smokers receiving vitamin cocktail · Male smokers selected for low fruit and vegetable intake | 31 mg | 272 mg | 90 days | 37 |
| Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke 2005 · Treatment group · Acute ischaemic stroke patients treated within 12 hours of symptom onset | 800 IU | 500 mg | 2 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 800 IU | 500 mg | 2 weeks | 24 |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy | 825 mg | 450 mg | 3 weeks | 16 |
| Combined effect of antioxidant supplementation and resistance training on oxidative stress markers, muscle and body composition in an elderly population 2011 · AS (vitamin C and E supplementation) · Healthy sedentary adults aged 59–73 years, men and women | 400 IU | — | 26 weeks | 14 |
| Combined effect of antioxidant supplementation and resistance training on oxidative stress markers, muscle and body composition in an elderly population 2011 · AS + RT (vitamin C and E supplementation combined with resistance training) · Healthy sedentary adults aged 59–73 years, men and women | 400 IU | — | 26 weeks | 14 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · low dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 200 IU | 250 mg | 2 weeks | 12 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · medium dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 400 IU | 500 mg | 2 weeks | 12 |
| The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C 2009 · high dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years | 800 IU | 1 g | 2 weeks | 12 |
| Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study 2003 · Supplemented women · Pregnant women starting supplementation at 35 weeks' gestation | 400 IU | 500 mg | — | — |
| Differential response of plasma and immune cell's vitamin E levels to physical activity and antioxidant vitamin supplementation 2005 · supplemented group · trained male amateur runners aged 32–36 years who participated in a half-marathon | 50 mg | 152 mg | 30 days | — |
| Antioxidant vitamin supplementation prevents oxidative stress but does not enhance performance in young football athletes 2019 · antioxidant-supplemented · Young football athletes; age and sex not specified | 400 IU | 500 mg | 15 days | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 600 mg | 750 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 15 mg | 120 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common | 15 mg | 120 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 15 mg | 120 mg | 1 year | — |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group MV · Adults with type 2 diabetes; age and sex not reported | 150 mg | 200 mg | 90 days | 17 |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 15 mg | 85 mg | 165 days | 749 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 40 mg | 80 mg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 40 mg | 80 mg | 24 weeks | 201 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 15 mg | 85 mg | — | 176 |
| Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial 2019 · intervention group · Children aged 6–9 months at the start of the study, male or female, attending primary health care centers in Goiânia, Brazil | 5 mg | 30 mg | 90 days | 107 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 250 IU | 100 mg | 180 days | 52 |
| [Effects of vitamins E, C and beta-carotene on DNA damage] 1999 · trial group · Healthy men aged 50–59 years | 280 mg | 100 mg | 20 weeks | 50 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 250 IU | 100 mg | 180 days | 47 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · type 2 diabetes group · Adults with early-stage, untreated type 2 diabetes | 300 g | 250 mg | 15 days | 46 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · impaired glucose tolerance group · Adults with impaired glucose tolerance | 300 g | 250 mg | 15 days | 46 |
| Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls 2005 · healthy control group · Healthy adults | 300 g | 250 mg | 15 days | 46 |
| Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial 2005 · vitamin E and vitamin C group · Patients with asymptomatic or mildly symptomatic moderate chronic degenerative aortic stenosis, with or without concomitant coronary artery disease; age and sex not reported | 400 IU | 1 g | 26 weeks | 41 |
| Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients 2001 · combined vitamin C and E treatment · Adults with type 2 diabetes and persistent micro/macroalbuminuria (urinary albumin excretion rate 30–300 mg/24 h) | 680 IU | 1.25 g | 4 weeks | 30 |
| The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial 2021 · Group A · Women aged 15–45 with pelvic pain and laparoscopically confirmed stage 1–3 endometriosis | 800 IU | 1 g | 8 weeks | 30 |
| Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment 2005 · vitamin E plus vitamin C combination · Patients with histologically proven fatty liver disease and chronically elevated alanine aminotransferase despite a three-month reducing diet; age and sex distribution not stated | 600 IU | 500 mg | 26 weeks | 28 |
| High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy 2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery | 400 IU | 500 mg | 60 days | 26 |
| Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects 1998 · vitamin group · HIV-positive patients; age and sex not specified | 800 IU | 1 g | 90 days | 26 |
| Soy isoflavones improve bone metabolism in postmenopausal Japanese women 2004 · V · Women; a subgroup of the study participants was postmenopausal | 5 mg | 25 mg | 4 weeks | 24 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 800 IU | 500 mg | 2 weeks | 24 |
| Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients 2013 · vitamins E and C treatment phase · 12 women with variegate porphyria and 12 control women | 50 mg | 150 mg | 26 weeks | 24 |
| Antioxidant vitamins and low-density-lipoprotein oxidation 1993 · antioxidant supplementation · Adults; ages and health conditions not stated | 200 mg | 900 mg | 26 weeks | 22 |
| [A randomized single-blind trial of the effects of vitamins C and E in familial hypercholesterolemia] 2006 · vitamin therapy group · Girls and boys aged 2–18 years with heterozygous familial hypercholesterolemia and LDL-cholesterol above 160 mg/dl | 400 IU | 1 g | 1 year | 21 |
| Boosting Antioxidant Defense: The Effect of Astaxantin on Superoxidase Dismutase and Malondialdehyde Reduction in Patients with Head and Neck Cancer Receiving Cisplatin Chemotherapy 2024 · Vitamin C and E group · Patients aged over 11 and under 80 with stage II–IV head and neck cancer receiving cisplatin chemotherapy; males and females | 250 IU | 500 mg | 3 weeks | 21 |
| Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial 1992 · active treatment · Patients with recurrent non-gallstone pancreatitis | 270 IU | 540 mg | 10 weeks | 20 |
| Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study 2018 · antioxidant group · Healthy males | 900 IU | 1 g | 8 weeks | 20 |
| Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial 2002 · vitamin group · cardiac transplant recipients 0–2 years after transplantation | 800 IU | 1 g | 1 year | 19 |
| Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men 2006 · Daily vitamin C and vitamin E supplementation · Healthy men | 272 IU | 500 mg | 4 weeks | 19 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group V · Patients with type 2 diabetes; age range and sex not specified | 100 IU | 200 mg | 90 days | 18 |
| Oxidative stress response to aerobic exercise: comparison of antioxidant supplements 2006 · V treatment · Aerobically trained men and women | 400 IU | 1 g | 2 weeks | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 400 mg | 452 mg | 1 day | 15 |
| Antioxidant Supplementation Protects Elite Athlete Muscle Integrity During Submaximal Training 2022 · antioxidant supplementation (AS) · Elite-level endurance athletes | 1,000 IU | 1 g | 6 weeks | 15 |
| Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise 2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years | 90 mg | 900 mg | 7 days | 12 |
| Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation 1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified | 800 IU | 1 g | 90 days | 12 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 300 mg | 600 mg | 48 weeks | 11 |
| Protective effect of alpha-tocopherol and L-ascorbic acid against the ischemic-reperfusion injury in patients during open-heart surgery 1991 · Group 2 · Adults undergoing cardiopulmonary bypass for treatment of cardiac disease; age and sex not reported | 2,000 IU | 2 g | 1 day | 11 |
| Effects of supplementation of antioxidant vitamins and lipid peroxidation in critically ill patients 2013 · G2 · Critically ill patients; age and sex not reported | 400 mg | 600 mg | 8 days | 11 |
| Effect of nutrition intervention on antioxidant capacity and lipid peroxide in patients with bone marrow transplantation 2002 · experimental group · Bone marrow transplantation recipients; age and sex not reported | 600 mg | 300 mg | 15 days | 10 |
| Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients 2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported | 400 IU | 500 mg | 26 weeks | 10 |
| Phototoxic lysis of erythrocytes from humans is reduced after oral intake of ascorbic acid and d-alpha-tocopherol 1997 · vitamins group · Human volunteers; age and sex not specified; no stated condition | 1,000 IU | 2 g | 7 days | 10 |
| Combined antioxidant treatment effects on blood oxidative stress after eccentric exercise 2005 · antioxidant supplement · Women aged 19–31 years who were not resistance-trained, undergoing eccentric elbow-flexor exercise | 400 IU | 1 g | 16 days | 9 |
| Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid 1993 · Group 4, alpha-tocopherol and ascorbic acid · Young healthy adults; age range and sex not reported | 1 g | 1 g | 4 weeks | 8 |
| Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle 2004 · Treatment · Young healthy men | 400 IU | 500 mg | 4 weeks | 7 |
| Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment 2003 · antioxidant supplementation · 11 antiphospholipid antibody-positive patients | 900 IU | 2 g | 6 weeks | 6 |
| Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients 2005 · EPA group · Patients with chronic hepatitis C receiving interferon alpha-2b and ribavirin; age and sex not reported | 300 mg | 600 mg | 24 weeks | 5 |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 30 mg | 120 mg | 2 years | — |
| Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes 2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified | 500 mg | 1 g | 90 days | — |
| Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial 2002 · vitamins C + E · nonsmokers | 400 IU | 500 mg | 60 days | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 200 mg | 300 mg | 8 weeks | — |
| Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial 2003 · vitamins E and C · Adults with stable, inactive or mildly active Crohn's disease and oxidative stress | 800 IU | 1 g | 4 weeks | — |
| Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers 2003 · group B · Healthy smokers; age range and sex not reported | 400 IU | 2 g | 4 weeks | — |
| Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers 2003 · group C · Healthy smokers; age range and sex not reported | 800 IU | 2 g | 4 weeks | — |
| Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers 2003 · Vitamins before breakfast · 11 people with type 2 diabetes | 800 IU | 1 g | 1 day | — |
| Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers 2003 · Vitamins before supper · 11 people with type 2 diabetes | 800 IU | 1 g | 1 day | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 30 mg | 120 mg | 3 weeks | — |
| Antioxidant vitamins decrease exercise-induced QT dispersion after myocardial infarction 2003 · vitamin C and E · Patients with acute myocardial infarction; age and sex not specified | 600 mg | 600 mg | 2 weeks | — |
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers 2003 · group B · Healthy young chronic smokers; age and sex not specified | 400 IU | 2 g | 4 weeks | — |
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers 2003 · group C · Healthy young chronic smokers; age and sex not specified | 800 IU | 2 g | 4 weeks | — |
| Antioxidant diet supplementation influences blood iron status in endurance athletes 2004 · antioxidant supplemented · Amateur trained male endurance athletes | 500 mg | 1 g | 90 days | — |
| Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone 2004 · vitamin supplement group · Children with asthma living in Mexico City | 50 mg | 250 mg | 120 days | — |
| Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers 2005 · antioxidant vitamin supplementation · smokers who smoked at least 10 cigarettes per day and had serum cotinine of at least 25 ng/mL; both men and women enrolled | 400 IU | 500 mg | 456 days | — |
| Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study 2005 · vitamin-treated group · Patients with systemic lupus erythematosus (SLE); age and sex not stated | 800 IU | 500 mg | 12 weeks | — |
| Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment 2005 · antioxidant treatment group · Men with unexplained infertility and at least 15% DNA-fragmented spermatozoa in the ejaculate | 1 g | 1 g | 60 days | — |
| Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise 2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified | 500 mg | 1 g | 90 days | — |
| Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans 2006 · CEalpha · Young men | 400 IU | 500 mg | 4 weeks | — |
| Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans 2006 · CEalphagamma · Young men | 420 IU | 500 mg | 4 weeks | — |
| A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins 2006 · micronutrient supplementation · Disease-free people in a rural Chinese population; age and sex not specified | 200 IU | 500 mg | 2666 days | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years | 800 IU | 500 mg | 8 weeks | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years | 800 IU | 500 mg | 8 weeks | — |
| Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables" 2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified | 24 mg | 150 mg | 4 weeks | — |
| Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen 2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated | 500 mg | 1 g | 90 days | — |
| Gender comparisons of exercise-induced oxidative stress: influence of antioxidant supplementation 2007 · antioxidant (A) · Men and women who ran for 30 minutes at 80% VO2 max; ages and health conditions not stated | 400 IU | 1 g | 2 weeks | — |
| Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants 2008 · antioxidant supplement (AS) · Overweight adults with BMI >27 kg/m²; age and sex not specified | 800 IU | 1 g | 7 days | — |
| Influence of an antioxidant vitamin-enriched drink on pre- and post-exercise lymphocyte antioxidant system 2008 · antioxidant supplementation · Male amateur trained runners aged 32–36 years | 50 mg | 152 mg | 30 days | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 1 · Adults aged 60–75 years; elderly participants | 200 mg | 300 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 2 · Adults aged 60–75 years; elderly participants | 200 mg | 300 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 3 · Adults aged 60–75 years; elderly participants | 200 mg | 300 mg | 16 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m² | 800 IU | 500 mg | 8 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m² | 800 IU | 500 mg | 8 weeks | — |
| Serum vaspin concentrations are decreased after exercise-induced oxidative stress 2010 · antioxidant supplementation · healthy young men after a standardized 4-week physical training program | 400 IU | 1 g | 4 weeks | — |
| Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation 2011 · n-3 PUFA plus antioxidant vitamins · Either-sex patients undergoing on-pump cardiac surgery | 400 IU | 1 g | — | — |
| Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation 2011 · Antioxidant vitamins C and E without n-3 PUFA · Either-sex patients undergoing on-pump cardiac surgery | 400 IU | 1 g | — | — |
| Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures 2012 · E/C/ALA · Adults aged 50–85 with probable Alzheimer disease and MMSE scores of 16 or more | 800 IU | 500 mg | 16 weeks | — |
| Prevention of neutrophil protein oxidation with vitamins C and E diet supplementation without affecting the adaptive response to exercise 2013 · antioxidant supplementation · Trained male amateur runners | 50 mg | 152 mg | 30 days | — |
| Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension 2014 · vitamin C + E · Men with essential hypertension; age range not reported | 400 IU | 1 g | 8 weeks | — |
| Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents 2014 · antioxidant supplementation · Overweight or obese children and adolescents; mean age 12.7 ± 1.5 years | 400 IU | 500 mg | 120 days | — |
| Antioxidants may Attenuate Plasma Erythropoietin Decline after Hyperbaric Oxygen Diving 2015 · vitamin group · healthy male police task force divers exposed to repeated hyperbaric oxygen diving | 600 IU | 1 g | 3 days | — |
| Vitamin C and E supplementation prevents some of the cellular adaptations to endurance-training in humans 2015 · antioxidant group · healthy young males | 400 IU | 1 g | 8 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration | 400 IU | 500 mg | 5 years | — |
| Lipid peroxidation and antioxidative vitamins under extreme endurance stress 1994 · Supplemented group · Trained long-distance runners; age and sex not reported | 400 IU | 200 mg | 32 days | — |
| Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise 1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years | 592 mg | 1 g | 6 weeks | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 75 mg | 650 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 15 mg | 120 mg | 26 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · mid-dose · Patients with established cardiovascular disease | 400 IU | 500 mg | 12 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · high dose · Patients with established cardiovascular disease | 800 IU | 1 g | 12 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 15 mg | 120 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 15 mg | 120 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 30 mg | 120 mg | 26 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia | 75 mg | 150 mg | 6 weeks | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 400 mg | 1 g | 4 weeks | 63 |
| Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk 2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls | 100 mg | 100 mg | 12 weeks | 53 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 100 mg | 300 mg | 8 weeks | 41 |
| Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status 1991 · antioxidant-supplemented men · Men with low antioxidant status | 300 mg | 600 mg | 150 days | 39 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 45 mg | 135 mg | 12 weeks | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 90 mg | 270 mg | 6 weeks | 30 |
| Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial 1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day | 200 mg | 400 mg | 90 days | 20 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group MV · Patients with type 2 diabetes; age range and sex not specified | 100 IU | 200 mg | 90 days | 17 |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 400 IU | 500 mg | 2 weeks | — |
| Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation 2004 · antioxidant mixture · Healthy adult men and women who were active or passive smokers | 794 mg | 515 mg | 60 days | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 30 mg | 120 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 400 IU | 500 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 800 mg | 1 g | 120 days | — |
| Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise 2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated | 30 mg | 60 mg | 6 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 400 IU | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 400 IU | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 400 IU | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 400 IU | 500 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 400 IU | 500 mg | 5 years | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · antioxidants · male smokers with combined hyperlipidemia | 75 mg | 150 mg | 6 weeks | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia | 75 mg | 150 mg | 6 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia | 75 mg | 150 mg | 6 weeks | — |
| Does combined antioxidant vitamin supplementation blunt repeated bout effect? 2015 · supplement (S) group · moderately trained males | 400 IU | 1 g | 2 weeks | — |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · Healthy control group · Healthy controls | 825 mg | 450 mg | 3 weeks | 10 |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration | 400 IU | 500 mg | 2433 days | — |